Clinical Trials · NCT03756116

Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide

Phase
N/A
Recruitment status
Unknown
Sponsor
The Second Hospital of Nanjing Medical University
Enrollment
2,000
Start date
Oct 2018
Locations
1 site, China
Primary endpoint
Incidence of post-ERCP pancreatitis in the groups
View Octreotide compound reference